The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults

This study has been completed.
Sponsor:
Information provided by:
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT00179530
First received: September 13, 2005
Last updated: November 2, 2007
Last verified: November 2007
  Purpose

To evaluate whether a 5-week relaxation response intervention influences the learning, memory or attention of healthy older adults.


Condition Intervention Phase
Healthy
Behavioral: Relaxation Response
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults

Resource links provided by NLM:


Further study details as provided by Beth Israel Deaconess Medical Center:

Primary Outcome Measures:
  • Evaluate whether a RR training program would decrease anxiety levels, improve attention, declarative memory performance in healthy older adults. [ Time Frame: 8 weeks ]

Secondary Outcome Measures:
  • Evaluate whether a RR training program would decrease salivary cortisol levels in healthy older adults. [ Time Frame: 8 weeks ]

Enrollment: 16
Study Start Date: May 1999
Study Completion Date: September 2007
Intervention Details:
    Behavioral: Relaxation Response
    Relaxation training
  Eligibility

Ages Eligible for Study:   65 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 65 to 80 years od age
  • No prior or current psychiatric or neurological condition.
  • score above 24 on the Mini-Mental State Exam (MMSE)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00179530

Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Investigators
Principal Investigator: Jeffery A Dusek, PhD Beth Israel Deaconess Medical Center, Mind/Body Medical Institute
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00179530     History of Changes
Other Study ID Numbers: 2001-P-002249
Study First Received: September 13, 2005
Last Updated: November 2, 2007
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Hydrocortisone
Anti-Inflammatory Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on July 24, 2014